Annals of Oncology 13:209-217, 2002
© 2002 European Society for Medical Oncology
Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation
Department of Medicine V, University of Heidelberg, Hospitalstrasse 3, D-69115 Heidelberg, Germany
Received 26 June 2001; revised 23 August 2001; accepted 7 September 2001.
Background
In this study, we report on quality of life (QOL) in long-term survivors after high-dose chemotherapy and autologous stem cell transplantation (ASCT) with special emphasis on rehabilitation in social and professional life.
Patients and methods
The European Organization of Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)-C30 questionnaire was sent by mail to 391 patients 1 to 12 years (median 31 months) after ASCT. The procedure was performed at our institution alone. Of the questionnaires 78% were returned and evaluated.
Results
Of the 238 patients who had an occupation and were employed, 132 (55%) have returned full time (68%) or part time (32%) to their previous occupation. A total of 139 patients (46%) received a 3- to 4-week inpatient rehabilitation treatment in specialised institutions following ASCT. Employment status post-transplantation and QOL were similar in these patients as compared with those who did not participate in rehabilitation programmes. Of the 304 evaluable patients, 39% reported physical problems that reduced their satisfaction with sex and intimacy. The general QOL was significantly reduced in the first year, improved with interval to transplant, and reached the level of the general population after 4 years.
Conclusions
Our retrospective data showed that ASCT has a significant, unfavourable impact on QOL, including reintegration into social and professional life. Most symptoms and scores returned to normal after 3 to 6 years. Employment status and QOL were similar in patients who participated in a rehabilitation programme and those who did not.
Key words: blood stem cell transplantation, high-dose chemotherapy, quality of life, rehabilitation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. G. E. M. de Boer and M. H. W. Frings-Dresen Employment and the common cancers: return to work of cancer survivors Occup. Med., September 1, 2009; 59(6): 378 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kim, R. Schulz, and C. S. Carver Benefit Finding in the Cancer Caregiving Experience Psychosom Med, April 1, 2007; 69(3): 283 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Lavoie, J. M. Connors, G. L. Phillips, D. E. Reece, M. J. Barnett, D. L. Forrest, R. D. Gascoyne, D. E. Hogge, S. H. Nantel, J. D. Shepherd, et al. High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver Blood, August 15, 2005; 106(4): 1473 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Andrykowski, M. M. Bishop, E. A. Hahn, D. F. Cella, J. L. Beaumont, M. J. Brady, M. M. Horowitz, K. A. Sobocinski, J. D. Rizzo, and J. R. Wingard Long-Term Health-Related Quality of Life, Growth, and Spiritual Well-Being After Hematopoietic Stem-Cell Transplantation J. Clin. Oncol., January 20, 2005; 23(3): 599 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Syrjala, S. L. Langer, J. R. Abrams, B. Storer, J. E. Sanders, M. E. D. Flowers, and P. J. Martin Recovery and Long-term Function After Hematopoietic Cell Transplantation for Leukemia or Lymphoma JAMA, May 19, 2004; 291(19): 2335 - 2343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Socie, N. Salooja, A. Cohen, A. Rovelli, E. Carreras, A. Locasciulli, E. Korthof, J. Weis, V. Levy, and A. Tichelli Nonmalignant late effects after allogeneic stem cell transplantation Blood, May 1, 2003; 101(9): 3373 - 3385. [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Cole and S. J. Scialla Does rehabilitation have a place in oncology management? Ann. Onc., February 20, 2002; 13(2): 185 - 186. [Full Text] [PDF]
|
|